GB2242195A - Absorbent structures with gelling agent and absorbent articles containing such structures - Google Patents

Absorbent structures with gelling agent and absorbent articles containing such structures Download PDF

Info

Publication number
GB2242195A
GB2242195A GB9105295A GB9105295A GB2242195A GB 2242195 A GB2242195 A GB 2242195A GB 9105295 A GB9105295 A GB 9105295A GB 9105295 A GB9105295 A GB 9105295A GB 2242195 A GB2242195 A GB 2242195A
Authority
GB
United Kingdom
Prior art keywords
gelling agent
particles
absorbent
particle size
structures
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB9105295A
Other versions
GB9105295D0 (en
GB2242195B (en
Inventor
Stephen A Goldman
James C Horney
Herbert L Retzsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB8819795A external-priority patent/GB2208804B/en
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of GB9105295D0 publication Critical patent/GB9105295D0/en
Publication of GB2242195A publication Critical patent/GB2242195A/en
Application granted granted Critical
Publication of GB2242195B publication Critical patent/GB2242195B/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/53Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42Use of materials characterised by their function or physical properties
    • A61L15/60Liquid-swellable gel-forming materials, e.g. super-absorbents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F220/00Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
    • C08F220/02Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
    • C08F220/04Acids; Metal salts or ammonium salts thereof
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08FMACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F251/00Macromolecular compounds obtained by polymerising monomers on to polysaccharides or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/53Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
    • A61F13/531Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having a homogeneous composition through the thickness of the pad
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84Accessories, not otherwise provided for, for absorbent pads
    • A61F13/8405Additives, e.g. for odour, disinfectant or pH control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/15203Properties of the article, e.g. stiffness or absorbency
    • A61F2013/15284Properties of the article, e.g. stiffness or absorbency characterized by quantifiable properties
    • A61F2013/15365Dimensions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/15203Properties of the article, e.g. stiffness or absorbency
    • A61F2013/15284Properties of the article, e.g. stiffness or absorbency characterized by quantifiable properties
    • A61F2013/15365Dimensions
    • A61F2013/15373Calliper, i.e. thickness
    • A61F2013/15382Reduced thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/15203Properties of the article, e.g. stiffness or absorbency
    • A61F2013/15284Properties of the article, e.g. stiffness or absorbency characterized by quantifiable properties
    • A61F2013/15422Density
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/45Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the shape
    • A61F13/47Sanitary towels, incontinence pads or napkins
    • A61F2013/4708Panty-liner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/51Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers
    • A61F13/514Backsheet, i.e. the impermeable cover or layer furthest from the skin
    • A61F13/51401Backsheet, i.e. the impermeable cover or layer furthest from the skin characterised by the material
    • A61F2013/51409Backsheet, i.e. the impermeable cover or layer furthest from the skin characterised by the material being a film
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/53Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
    • A61F2013/530007Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium being made from pulp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/53Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
    • A61F2013/530481Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials
    • A61F2013/530489Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials being randomly mixed in with other material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/53Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
    • A61F2013/530481Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials
    • A61F2013/530569Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials characterized by the particle size
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/53Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
    • A61F2013/530481Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials
    • A61F2013/530583Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials characterized by the form
    • A61F2013/530591Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials characterized by the form in granules or particles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/53Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
    • A61F2013/530481Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials
    • A61F2013/5307Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials characterized by the quantity or ratio of superabsorbent material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/53Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
    • A61F2013/530481Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials
    • A61F2013/530708Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having superabsorbent materials, i.e. highly absorbent polymer gel materials characterized by the absorbency properties
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00Bandages or dressings; Absorbent pads
    • A61F13/15Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
    • A61F13/84Accessories, not otherwise provided for, for absorbent pads
    • A61F2013/8488Accessories, not otherwise provided for, for absorbent pads including testing apparatus
    • A61F2013/8491Accessories, not otherwise provided for, for absorbent pads including testing apparatus including test methods

Abstract

The present invention relates to absorbent structures and absorbent gelling agent compositions suitable for use in disposable absorbent articles such as diapers, incontinence products and catamenial products. The absorbent structures comprise hydrophilic fiber material and nonfragile particles of polymeric galling agent. The gelling agent particles incorporated into such structures are selected to have a mass median particle size ranging from about 400 to 1680 microns, preferably with the amounts of very large and very small particles kept below certain minimum concentrations. Absorbent structures utilizing gelling agent particles of such particle size characteristics possess unexpectedly high absorbent capacities and the gelling agent therein can be utilized very efficiently and effectively.

Description

ABSORBENT STRUCTURES WITH GELLING AGENT AND ABSORBENT ARTICLES CONTAINING SUCH STRUCTURES Stephen A. Goldman James C. Horney Heriert L. Retzsch The present invention relates to fibrous web structures suitable for absorbing discharged body fluids, to an improvement in the common process for the manufacture of such structures, and to absorbent gelling agent compositions especially useful in these structures. Such structures can be incorporated into disposable absorbent articles such as sanitary napkins, infant diapers, adult incontinence pads and the like.
BACKGROUND OF THE INVENTION The present invention relates to fibrous web structures suitable for absorbing discharged body fluids and to absorbent galling agent compositions especially useful in these structures.
Such structures can be incorporated into disposable absorbent articles such as sanitary 'napkins, infant diapers, adult incontinence pads and the like.
Absorbent structures which comprise entangled wastes of fibers, i.e., fibrous webs, are well known in the art. Such sti ures can imbibe liquids, such as discharged body fluids, botn by an absorption mechanism wherein fluff is token up by the fiber material itself and by a wicking mechanism wherein fluid is acquired- by, distributed through and stored in the capillary interstices between fibers. One means for improving the absorbency characteristics of such fibrous web structures is to incorporate therein so.called superabsorbent polyiners which imbibe fluid to thereby fonr a swollen hydrogel watarial. The resulting hydrogel serves to retain fluid such as discharged body liquids within the structure. An absorbent structure of this type wherein hydrogel.forning inaterials in particulate (including fiber) form are incorporated into fibrous webs is disclosed in Weisman and Gold@an; U.S. Patent 4,610,678; Issued September 9, 1986.
Prior to the date of the present invention, the size and configuration of particle#forming hydrogel-forming polymers (i.e. gelling agents) incorporated into absorbent structures have not been considered to be parameters which affect the absorption characteristics of the structures containing them, and wide ranges of particle sizes have been proposed.
The above-cited U.S. Patent 4,610,678, for example, indicates that gelling agent particles incorporated into such absorbent structures can range in size fro about 30 microns to about 4 mm. In actual cormnercial practice, however. the particles of gelling agent employed in absorbent cores for disposable diapers are frequently irregular but not highly elongated in configuration, range in particle size from about 45 to 850 microns and have a mass median particle size of from about 200 to 370 microns. Particles of this shape and size are generally selected because of industrial hygiene and ease.of-processing considerations.
Some commercially available gelling agent materials are furthermore produced in the form of particles which are agglomerates of smaller particles since the larger agglomerates are easier to handle in gelling agent synthesis and packaging opera tions. It is believed, however, that agglomerates of this type break down to some degree during their incorporation into dis- posable absorbent articles manufactured in commercial operations and during subsequent use of such articles. Products of this type such as diapers thus may actually contain gelling agent in the form of particles that are somewhat smaller than the gelling agent agglomerates originally provided in raw material form for diaper-making operatfons.
Whatever the size and form of gelling agent pai des employed in known absorbent structures, the gelling agent is generally more expensive than the staple fiber component which forms the principal part of the structure. Accordingly, the materials, configurations and processing used in making such absorbent structures are often manipulated and adjusted in order to maximize the absorbent capacity of the absorbent structure and the effective absorbent capacity of the gelling agent material employed in the structure. In this manner. the minimum amount of gelling agent consistent with the realization of desired absorbent performance objectives can be used. This, An turn, tends to minimize the cost of producing the absorbent structure.
Given the fact that there is a continuing need to improve absorbent structure absorbency characteristics, it is an objective of the present invention to provide a type of absorbent structure configuration wherein structure absorbent capacity and effective capacity of the gelling agents therein can be improved.
It is a further object of this invention to provide such absorbent structures of improved absorbent capacity and gelling agent efficiency by the simple adjustment and control of particle size distribution of the gelling agent materials employed in the absorbent structure.
It is a further object of the present invention to provide gelling agent compositions which have controlled particle size characteristics and which are especially suitable for incorporation into stch abscrbent structures.
It is a further object of the present invention to provide disposable absorbent articles such as diapers, training pants, incontinence pads, sanitary napkins and the like, which utilize such absorbent structures of improved absorbency characteristics to form their absorbent cores.
SUMMARY OF THE INVENTION According to one aspect of the invention there is provided a liquid.
absorbent structure comprising a web having a density of from 0.06 to O.3g/cm3, said web comprising from 40% to 95% by weight of hydrophilic fibres and from 5% to 60% by weight of nonfibrous particles of hydrogel-forming gelling agent thoroughly dispersed among the hydrophilic fibres in the web, which polymeric gelling agent has an equilibrium gel volume of at least 20 grams of synthetic urine per gram of gelling agent, wherein when dispersed as aforesaid among the hydrophilic fibres in the web the said particles are discrete non-agglomerated particles having a mass median particle size in the range from 400 to 700 micrometers with no more than 16% by weight of these particles having a particle size less than 200 micrometers and no more than 16% by weight of these particles having a particle size greater than 1000 micrometers, with the result that the effective equilibrium absorbent capacity of the said particles when in the said structure is greater than the corresponding effective equilibrium absorbent capacity of the particles in a comparative structure differing in composition and construction from the first above-mentioned only in that the particles in the said comparative structure have a mass median particle size less than 400 micrometers.
In another aspect of the invention, absorbent articles are provided of improved absorbency chatacteristics. Such articles comprise a liquid impervious backing sheet, a liquid pervious topsheet and an absorbent core positioned betweeen the backing sheet and the topsheet. The absorbent core comprises an absorbent web structure of the type as hereinbefore described.
In a further aspect of the invention, there is provided an improvement in the preferred known process for manufacturing absorbent structures wherein non-fibrous particles of hydogel-forming polymeric agent are fed from a source thereof which is periodically restocked, to be thoroughly dispersed among hydrophilic fibres, and a web is laid down from the said resultant thorough mixture of particles and fibres, the improvement comprising controlling the supply of particles at or from the said source thereof such that the particles are discrete non-agglomerated particles or nonfragile agglomerated particles and have a mass median particle size within certain defined limits.
BRIEF DESCRIPTION OF THE DRAWING The drawing submitted herewith represents a cutaway view of a disposable diaper which is a preferred configuration for the absorbent articles herein.
DETAILED DESCRIPTION OF THE INVENTION The absorbent structures of the present invention are webs or batts which contain both fibrous and nonffbrous components, and the gelling agent compositions of the present invention contain only nonfibrous components.For purposes of this Inven- tion, the terms "fibers" and "fibrous" refer to a specific type of "particulate" material wherein the length tu diameter ratio of the majority of such particulate material is greater than about 10. "Nonfibrous" particles, conversely, are those wherein the length to diameter ratio of the majority is about J O or less - In the first of its several embodflments, the present inven tion relates to absorbent structures which comprise fibrous webs containing nonfibrous particles of absorbent gelling agent material The principal component of these absorbent web structures comprises hydrophilic fiber material.For purposes of the present invention, a fiber is " hydrophiljc# if water or aqueous body fluid readily spreads on or over the surface of the fiber (without regard to whether or not the fiber actually imbibes fluid or forms a gel). The hydrophilic fibers which are employed will generally have an average diameter which ranees from about 1 to 200 micrometers, more commonly referred to as microns. More preferably, the average diameter of these hydrophilic fibers will range from about 10 to 100 microns.
Substantially all of the hydrophilic fibers incorporated into the structures herein preferably have a fiber length of at least 1 mm.
The type of hydrophilic fiber material is not critical for use in the structures of the present invention. Any type of hydrophilic fiber which is suitable for use in conventional absorbent products is also suitable for use in the absorbent structures herein. Examples of hydrophilic fiber material include cellulose, modified cellulose, rayon, polyesters such as polyethylene terephthalate DACRON (RTM) hydrophilic nylon HYDROFIL (RTM), and the like.
Suitable hydrophilic fibers also Include hydrophobic fibers which have been hydrophilized with a hydrophilizing agent. Such fibers include surfactant-treated or silica-treated thermoplastic fibers derived, for example, from polyolefins such as polyethyt ene or polypropylene, polyacrylics, polyamides, polystyrenes, polyurethanes and the like. In fact, hydrophilized hydrophobic fibers which are in and of themselves not very absorbent and which. therefore, do not provide webs of sufficient absorbent capacity to be useful in conventional absorbent structures, are suitable for use in the structures of this invention by virtue of their good wicking properties. This is because, in the structures herein, wicking propensity of the fibers is far more Important than the absorbent capacity of the fiber material itself.
For reasons of availability and cost, cellulose fibers are generally preferred for use herein as the hydrophilic fiber component of the web structure. Most preferred are wood pulp fibers.
Other cellulosic fiber materials which may be especially useful in certain absorbent structures herein are the stiffened, twisted, curled, cellulose fibers which can be produced by internally cross-linking cellulose fibers with a cross-llnk1ng agent. Fibers of this general type are disclosed, for example, in Bernardin, U.S. Patent 3,224,926, Issued December 21, 1965; Stetger, U.S. Patent 3,241,553, Issued March 22, 1966, Chung, U.S. Patent 3,440.135. Issued April 22, 1969; Steiger, U.S.
Patent 3,658,613, Issued April 26, 1972; Chatterjee, t).S. Patent 3,932,209, Issued January 13, 1976 and Sangenis et al, U.S.
Patent 4,035,147, Issued July 12, 1977, all of which patents are incorporated herein by reference.
One especially preferred type of stiffened, twisted, curled cellulose fibers useful as the hydrophilic fiber component of the absorbent web structures herein comprises cellulose fibers which have been internally crosslinked, for example with a C2-C8 dlal- dehyde, while such fibers are in a relatively dehydrated state.
Such fibers can be defined in terms of their dry fiber and wet fiber twist counts (at least 4.5 twist nodes per millimeter dry and at least O.S twist nodes per millimeter less than that when wet and preferably also at least about 3.0 twist nodes per m111t- meter wet) and by their fluid retention characteristics (average isopropyl alcohol retention value of less than 30X; average water retention value of from 28X to Soy). Stiffened, twisted, curled cellulosic fibers of this type are described in greater detail in European Patent Publication No. 251,676; Published January 7, 1988 and in European Patent Publication No. 252,650;Published January 13, 1988. Both of these published patent applications were filed in the name of The Procter & Gamble Company and both are incorporated herein by reference.
The hydrophilic fiber component of the structures herein will generally comprise fro about 40X to 95Z by weight of the structure, more preferably fro about 60X to 95X by weight. Most preferably, the hydrophtlflc fiber component will comprise fron about 70X to 90X by weight of the structure. These concentra tions of hydrophilic fiber material include the weight of hydro philizing agent, if any, employed thereon.
The second essential component of the absorbent structures herein comprises discrete, nonfibrous, nonfragile particles of a particular type of polymeric gelling agent. These polymeric gelling agents are those materials which, upon contact with fluids (i.e., liquids) such as water or body fluids, imbibe such fluids and thereby form hydrogels. In this manner, fluid dis- charged into the absorbent structures herein can be acquired and held by the particles of the polymeric gelling agent, thereby providing the structures herein with enhanced absorbent capacity and/or improved fluid retention performance.
The polymeric gelling agent particles which are employed will generally comprise a substantially water-insoluble, slightly cross-linked, partially neutralized, hydrogel-forming polymer material. Such polymer materials can be prepared from polymertz- able, unsaturated, acid-containing monomers. Thus, such monomers Include the olefinically unsaturated acids and anhydrides which contain at least one carbon to carbon olefinic double bond. More specifically, these monomers can be selected from olefinically unsaturated carboxylic acids and acid anhydrides, olefinically saturated sulfonic acids and mixtures thereof.Upon polymert- ration, monomeric units of this type will comprise from about 50 mole percent to 99.999 mole percent, more preferably from about 75 mole percent to 99.99 mole percent of the gelling agent material.
Suitable unsaturated actdtc monomers for use in preparing the polymeric gelling agents used in this invention include those listed in Brandt/Goldman/Ingiln; U.S. Patent 4,654,039, Issued March 31, 1987, and in its allowed reissue application Serial No.
060,718, Piled June 10, 1987, both of which are incorporated herein by reference. Preferred monomers include acrylic acid, methacrylic acid, and 2-acrylamido- 2-methyl propane sulfonic acid. Acrylic acid Itself is especially preferred for prepara tton of the polymeric gelling agent material.
In the hydrogel-fonning Polymeric gelling agent the poly merle component formed from unsaturated, acid-containing monomers may be grafted on to other types of polymer moieties such as starch or cellulose. Acrylic acid grafted starch materials of this type are also especially preferred for use herein.
Preferred polymer gelling agents which can be prepared from conventional types of monomers include hydrolyzed acrylonitrile grafted starch, acrylic acid grafted starch, polyacrylates, inaleic anhydride copolymers and combinations thereof. Especially preferred are the polyacrylates and acrylic acid grafted starch.
Whatever the nature of the basic polymer components of the hydrogel-forming polymeric gelling agents used In the absorbent structures herein, such materials will in general be slightly cross-linked. Cross-linking serves to render the hydrogel- forming polymer gelling agents used in this invention substantially water-insoluble, and cross-linking thus in part determines the gel volume and extractable polymer characteristics of the hydrogels formed from the polymeric gelling agents employed.
Suitable cross-linking agents are well known in the art and include, for example, those described in greater detail in Masudt et al; U.S. Patent 4,076,663; Issued February 28, 1978, incorporated herein by reference. Preferred cross-linking agents are the di- or polyesters of unsaturated mono- or polycarboxylic acids with polyols, the bisacrylamides and the d1- or triallyl gamines.
Especially preferred cross-linking agents are N,N'-methylenebis acrylamltc, trimethylol propane triacrylate and triallyl gamine.
The cross-linking agent can generally comprise from about 0.001 mole percent to 5 mole percent of the resulting hydrogel-forming polymer material. More preferably, the cross-linking agent will comprise from about 0.01 mole percent to 3 mole percent of the hydrogel-fonming polymeric gelling agent used herein.
The slightly cross-11nked, hydrogel-forming polymeric gelling agents which may be used in the structures of the present invention are generally employed in their partially neutralized form. For purposes of this invention, such materials are considered partially neutralized when at least 25 mole percent, and preferably at least 50 mole percent of monomers used to form the polymer are acid group-contatn1ng monomers which have been neutralized with a salt-foruing cation.Suitable salt-forming cations include alkali setal, ammonium, substituted ammonium and sines. This percentage of the total monomers utilized which are neutralized acid group-containing monomers is referred to herein as the "degree of neutral1zation.# Degree of neutralization will preferably not exceed 98X.
The polymeric gelling agent materials used in the absorbent structures herein must have a relatively high capacity for imbib- Rng fluids encountered in absorbent structures. The absorbent capacity of such materials can be quantified by referencing the "gel volumes of the polymeric gelling agents which are to be selected for use in the present invention.
For purposes of this invention, gel volume can be defined In terms of the amount of synthetic urine absorbed by any given polymeric gelling agent and is specified as grams of synthetic urine per gram of polymeric gelling agent. Gel volume in synthetic urine can be determined by forming a suspension of about 0.1-0.2 parts of dried polymeric gelling agent to be tested with about 20 parts of synthetic urine. This suspension is maintained at ambient temperature under gentle stirring for a time sufffcient, e.g., about 1 hour, for swelling equilibrium to be attained.Using e procedure described in greater detail iierein- after in the Test Methods section, the gel volume of the polymeric selling agent in grams of synthetic urine per gram of polymeric gelling agent is then calculated from the weight frac tion of the polymeric gelling agent in the suspension and the ratio of the liquid.volume excluded from the formed hydrogel to the total volume of the suspension.
The structures of the present invention, and especially the structures which are to be used in diapers, adult incontinence products or training pants, will generally employ polymeric gel 1 ing agents having z gel volume of at least about 20 grams of synthetic urine per gram of polymeric gelling agent. When the structures herein are constructed from cellulose fibers such as wood pulp fibers, It may be desirable to utilize polymer gelling agent having a somewhat higher gel volume, i.e., a gel volume between about 25 and 60 grams of synthetic urine per gram of gelling agent.
Structures constructed from certain types of cellulosic fiber material such as, for example, the stiffened, twisted, curled cellulose fibers hereinbefore described may actually be more effective at absorbing fluid if gelling agents of somewhat lower. gel volumes are employed. Gelling agent of generally lower gel volume tends to form hydrogels of generally higher gel strength (as quantified by hydrogel shear modulus in the manner described in the hereinbefore-referenced U.S. Patent 4,654,039 and U.S.Reissue Application Serial No, 060,718). thus, in structures wherein the hydrophilic fibers are stiffened, twisted, curled cellulose fibers, it may be preferable to employ polymeric gelling agent having a gel volume of from about 20 to 35 grams of synthetic urine per gram of gelling agent.
Another feature of the polymeric gelling agents which are especially useful in the absorbent structures herein relates to the level of extractable polymer material present in such hydrogel-forning material. Extractable polymer levels can be determined by contacting a sample of hydrogel-forming polymeric gelling agent material with a synthetic urine solution for the substantial period of time (e.g., at least 16 hours) which is needed to reach extraction #1uilibrium, by then filtering the formed hydrogel from the supernatant liquid, and finally by then determining the polymer content of the filtrate. the particular procedure used to determine extractable polymer content of the polymeric gelling agents used herein is also set forth in the hereinbefore referenced U.S. Patent 4,554,039 and Reissue Application Serial No. 060,718, Polymeric gelling agent materials especially useful in the structures herein are those which have an equilibrium extractabtes content in synthetic urine of no more than about 17%, preferably no more than about 10% by weight of the polymeric gelling agent.
An essential feature of the present invention is the utilization of the above-described polymeric gelling agents. in the structures herein in the fore of nonfibrous, nonfragile particles having certain particle size characteristics. In particular, it has been discovered that an unexpected improvement in absorbent structure capacity and effective gelling agent capacity within an absorbent structure can be realized by incorporating polymeric gelling agent into such absorbent structures in the form of particles which are generally larger than those which have heretofore been conventionally employed.
Generally, provision of gelling agent particles of this rela lively larger size requires the use of one or more manufacturing or processing techniques which eliminate or reduce the amount of smaller, finer gelling agent particles which are introduced, along with hydrophilic fiber, into the absorbent structures herein. An upper limit on gelling agent particle size is also provided since selling agent particles which are too large may be less desirable from a consumer aesthetics standpoint.
Specifically, the present invention requires the utilization in the absorbent structures herein of polymeric gelling agent particles of a selected mass median particle size and preferably a certain particle size deviation from the mass median particle size. For purposes of the present invention, particle size is defined as the dimension of a gelling agent particle which is determined by sieve size analysis.Thus, for example, in print~ ple, a particle that is retained on . sieve with 710 micron openings is considered to have a particle size greater than 710 microns, a particle that passes through a sieve with 710 micron openings and is retained on a sieve with 500 micron openings is considered to have a particle size between 500 and 710 microns, and a particle that passes through a sieve with 500 micron openings is considered to have a particle size less than 500 microns.
Further, for purposes of this invention, the mass median particle size of a given sample or plurality of gelling agent particles is defined as the particle size which divides the sample or plurality in half on a mass basis, i.e., half of the sample or plurality by weight will have a particle size greater than the mass median particle size and half of the sample or plurality by weight will have a particle size less than the mass median particle size. Thus, for example, the mass median particle size of a sample of gelling agent particles is 500 microns if one half of the sample by weight is retained on a sieve with openings of 500 microns.A standard particle-size plotting method (wherein cumulative weight percent of the particle sample retained on or passed through a given sieve size is plotted versus sieve-opening size on probability paper) is typically used to determine mass median particle size when the 50% mass value does not correspond to the size opening of a USA Standard Testing Sieve.
A plot of this type is also typically used to determine the distribution of particle size about the mass median value.
The polymeric gelling agent particles employed in the absorbent structures of this invention must have a mass median particle size ranging from about 400 to 700 microns with no more than 16% by weight of these gelling agent particles having a particle size less than 200 microns and no more than about 16% by weight of these particles having a particle size greater than 1000 microns.
More preferably, the mass median particle size of the gelling agent particles used in the structures herein will range from about 410 to 650 microns with no more than about 16% by weight of these particles having a particle size less than 210 microns and no more than about 16% by weight of these particles having a particle size greater than 1000 microns. Most preferably, the mass median particle size of the gelling agent particles will range from about 420 to 600 microns with no more than about 16% by weight of the particles having a particle size less than 220 microns and no more than about 16% by weight of the particles having a particle size greater than 900 microns.
Within the foregoing mass median particle size and particle size distribution limitations, it is possible to even further identify preferred particle size characteristics for the gelling agent particles useful herein by means of standard sieve analyses. In a typical sieve analysis, a sample or plurality of gelling agent particles is sifted through a set number of screens of diminishing screen opening size and the weight percent of the sample retained on and/or passing through each screen is determined. Standard methcde for making such sieve analyses have been established, for example, by the American Society for Testing Materials (ASTM). One such method employs a Ro-Tap testing sieve shaker (manufactured by W. S. Tyler, Inc.) and a series of screens identified by either U.S. Sieve Series or Tyler Standard Sieve Series designations.Determination of particle size distribution using such a technique is described in greater detail in Perry's Chemical Engineers' Handbook, Sixth Edition, (McGraw-Hill Book Company, 1984) at pp. 21z13 to 21-19, which publication is incorporated herein by reference.
Particle size distribution characteristics as determined by a typical Screen ASTM standard analysis for preferred and more preferred gelling agent samples of the present invention art .et forth as follows: U.S. Sieve More Series Tyler Preferred Preferred Screen Opening Alternate Equivalent Distribution Distribution Size (Microns) Desionation Dtsfgnation (Wt.X) ~ (wit.%) 1410 on No. 14 on 12 mesh < 0.1 0-0.05 1190 on No. 16 on 14 mesh C 1.0 O-O.S 841 on No. 20 on 20 mesh 10-35 15-25 297 on No. 50 on 48 mesh > 50 60-70 149 on No. 100 on 100 mesh C 15 10-14 149 thru No. 100 thru 100 mesh C 5 1-3 The polymeric gelling agent particles can be adjusted to, or close to, the requisite particle size distribution by controlling the processing techniques used to prepare the gelling agent.
Frequently this wilt involve varying and monitoring the conditions under which the gelling agent is polymerized, dried, chopped, ground and/or agglomerated. Once gelling agent particles are foreed by whatever process, further treatment such as screening may be required to remove particles which, if left in, would cause the gelling agent particle component to fall outside the scope of the hereinbefore-described particle size distribution requirements.
One preferred technique for preparing particles which are larger than those ordinarily prepared by gelling agent polymerfzat1on dryfln*-chopplng techr.iques involves agglomeratiet of smaller particles to produce larger agglomerates.
Agglomeration techniques can thus be used to raise the mass median particle size of gelling agent particles and to thereby provide particles in agglomerated form which are suitable for use in the structures herein. Agglveeration techniques are wall known in the art and may or may not involve the use of moisture addition to smaller gelling agent particles or the use of a binder or other type of agglomerating medluin.
Gelling agent particles used in the process for the manufacture of the absorbent structures herein, whether or not in agglomerated form, should be nonfragile. For purposes of the present invention, such particles are nonfragile if they are stable enough to withstand the forces encountered in conventional absorbent structure manufacture and/or use without breaking apart and unduly separating into smaller component particles. This means that the gelling agent particles of the invention should be stable enough that they do not break apart into smaller particles to the extent that the resulting aggregation of particles before swelling) falls outside the scope of the particle size limitations hereinbefore set forth.The nonfragility of a given batch of particles in any particular process for laying down a web of fibres comprising them, can be confirmed by, for example. sampling the resultant web in a manner statistically representative of the web structure as a whole, and carrying out a microscopic size analysis of the particles therein. To confirm that agglomerated particles are nonfragile at the point when contacted by body fluids, the behaviour of the agglomerates can be inspected under a microscope when contacted with representative volumes of synthetic urine.
If the agglomerated particles break apart before being swollen with the synthetic urine, they will not be nonfragile for the purposes of this invention Polymeric gelling agent particles having the requisite particle size distribution are Incorporated into the absorbent web structures of the present invention in a concentration of from about 5X to 60X by weight of the structure. Use of gelling agent levels below about 5X renders such structures less able to retain aqueous body fluids imbibed by the structure.At higher gelling agent concentrations, for example those above about 60X by weight and even above about 40X by weight, it is believed that the desirable effects of using generally larger gelling agent particles to improve absorbent capacity and effective gelling agent capacity wili diminish. Thus, preferably the gelling agent particles will comprise from about 1otto 40X by weight of the absorbent structures herein.
The absorbent structures herein can contain a variety of optional materials in addition to the essential hydrophilic fiber and polymeric gelling agent components. Such optional materials can include, for example, fluid distribution aids, antimicrobi- als, pH control agents, perfumes, etc. If present, these optional components will generally comprise no more than about 30N by weight of the structures herein.
The feature which distinguishes the process for manufacturing the absorbent structures of this invention from the preferred process of the prior art, is the control of the supply of gelling agent particles to the mixing stage (wherein they are thoroughly dispersed with the hydrophilic fibres prior to laying down the web) such that the particles are discrete non-agglomerated particles or nonfragile agglomerated particles, and have the defined mass median particle size characteristics.Providing such control over the supply of gelling agent particle characteristics is maintained, the absorbent structures herein with their essential hydro phil Ic fiber and polymeric gelling agent particulate components can be prepared by any process or technique which provides a web comprising a combination of the fibers and the nonfibrous gelling agent particles. Within such a fiberiparticle combination, the gelling agent particles should be thoroughly dispersed among the hydrophilic fibers forming the web.For purposes of this Inven- tion, gelling agent particles are "thoroughly dispersed" among the hydrophilic fibers if there are no significant instances of individual gelling agent particles being in contact only with each other and not with one or more hydrophilic fibers.
Preferably, this will mean that there should be no zones or regions (e.g., zones. or regions of 1 cubic centimeter or larger) within the absorbent structure wherein the concentration of gelling agent exceeds the 60% limit set forth hereinbefore.
Within the web structures herein, the particles of the polymeric gelling agent must be thoroughly dispersed but may or may not be uniformly distributed. In particular, there may be regions or zones of the web structures which have higher concen rations of gelling agent particles than do other regions or zones of the structure. In one embodiment of this type, there may be a concentration gradient of gelling agent particles along the thickness dimension of the structure with the lowest concentration of gelling agent being at or near the surface of the structure which receives fluid and the highest concentration of gelling agent being at or near the opposite end of the thickness dimension.
The density of the absorbent structures herein can be of some importance in determining the absorbent properties of the structures and of the absorbent articles in which such structures are employed. The density of the absorbent structures herein will generally be in the range of from about 0.06 to about 0.3 g/cm3, and more preferably within the range of from about 0.09 to about 0.22 g/cm3. Typically the basis weight of the absorbent structures herein can range from about 0.02 to 0.12 gm/cm2.
Density values for these structures are calculated from basis weight and caliper. Caliper is measured under a confining pressure of 0.137 psi (0.94 kPa). Density and basis weight values include the weight of the hydrogel-forming particles.
Density of the structures herein need not be uniform throughout the structures. Within the density ranges hereinbefore set forth, structures of this invention can contain regions or zones of relatively higher or relatively lower density.
Absorbent structures of this invention can be formed by air-laying a substantially dry mixture of hydrophilic fibers and polymeric gelling agent particles and, if desired or necessary, densifying the resulting web. Such a procedure is described more fully in Weisman and Goldman; U.S. Patent 4,610,678; Issued September 9, 1986, incorporated herein by reference.
As indicated in U.S. Patent 4,610,678, the afr-laid webs formed by this procedure will preferably comprise substantially unbonded fibers and will preferably have a moisture content of 10X or less. In preparing webs of this invention by an air-laying process or by any other conventional procedure, care should be taken in handling and transporting the polymeric gelling agent particles so as to avoid breaking these particles down into smaller particles. This is especially true when the gelling agent particles are in an agglomerated form wherein the agglomerates may be more friable than nonaggloMerated particles.
If the gelling agent particles, e.g., agglomerates, are roughly treated during web structure preparation or thereafter, the particles actually tncorporated into the structure (even though such particles are "nonfragtle") may not have the requisite particle size distribution characteristics set forth hereinbefore.
In another of its embodiments, the present invention relates to gelling agent compositions per Le which are especially suitable for incorporation as absorbents into fibrous absorbent web structures. Such compositicns comprise a plurality of nonfibrous, nonfragile particles of polymeric gelling agent material. The gelling agent material itself is of the same type as hereinbefore described in detail. The plurality of gelling agent particles likewise has the same particle size character istics as hereinbefore set forth for the gelling agent particles which are incorporated into the absorbent structure embodiments of this invention.
In yet another of its embodi#nts, the present invention relates to absorbent articles which utilize as an essential component an absorbent structure of the type hereinbefore described in Cstaft. By "absorbent article" herein is meant a consumer product which is capable of absorbing significant quantities of water and other fluids (i.e., liquids)0 like body fluids. Examples of absorbent articles include disposable diapers, sanitary napkins, incontinence pads, paper towels, facial tissues, toilet pads and the like.The absorbent structures of this invention are particularly suitable for use in articles like diapers, incontinence products, and sanitary napkins.
Absorbent articles herein will in general comprise a liquid impervious backing sheet, a liquid pervious, relatively hydro phobic topsheet and an absorbent core comprising an absorbent structure of the present invention positioned between the backing sheet and the topsheet Liquid impervious backing sheets can comprise any material, for example, polyethylene or polypropylene having a caliper of about 1.5 mills, which will help retain fluid within the absorbent article. Relatively hydrophobic, liquid pervious topsheets can comprise any material such as polyester, polyolefin, rayon and the like which is substantially porous and permits a fluid to readily pass therethrough into the underlying absorbent structure.
Particularly preferred absorbent articles herein are dis- posable diapers. Disposable diapers comprising the absorbent structures of the present invention may be made by using convey.
tional diaper making techniques, but by replacing or supplement Sng the wood pulp fiber web !'Safrf.lt") core which is typically used in conventional diapers with an absorbent structure of the present invention. Articles in the form of disposable diapers are fully described in Duncan and Baker, U.S. Patent Re 26,151, issued January 31, 1967; Duncan, U.S. Patent Patent 3,592,194, issued July 13, 1971; Duncan and Gellert, U.S. Patent 3,489,148, issued January 13, 1970; and Bull, U.S. Patent 3,860,003, issued January 14, 1975; which patents are incorporated herein by reference.A preferred disposable diaper for the purpose of this invention comprises an absorbent core containing an absorbent structure of this invention; a topsheet superposed or c"'-extensive with one face of the core, and a liquid impervious backsheet superposed or co-extensive with the face of the core opposite the face covered by the topsheet. The backsheet most preferably has a width greater than that of the core thereby providing side marginal portions of the backsheet which extend beyond the core. The diaper is preferably constructed in an hourglass configuration.
One embodiment of a disposable diaper article according to the present invention is shown in the drawing. The hourglassshaped diaper structure of the drawing comprises a liquid impervious backing sheet 101. Positioned on the top of the backing sheet 101 is an hourglass-shaped absorbent core 102 comprising the absorbent structure of the present invention.
This core contains hydrophilic fiber material such as wood pulp fiber. Also distributed throughout the absorbent core 102 are discrete particles 103 of polymeric gelling agent, which particles have the requisite size distribution hereinbefore described.
Positioned on top of the hourglass-shaped absorbent core 102 is liquid pervious topsheet 104.
Because the absorbent structures of the present invention have a high absorbent capacity for menstrual fluid as well as for urine, such structures, even though defined in terms of capacity for synthetic urine, are also quite suitable for use in sanitary napkins. As is the case with disposable diapers, sanitary napkins utilizing the present absorbent structures may be derived from conventitinal sanitary napkins by simply replacing or supplementing the absorbent core thereof (typically a web of wood pulp fibers) with the gelling agent-containing absorbent structure of the present invention.Such replacement may be on a weight-by-weight basis, which results in a reduction in volume and a gain in capacity; or the replacement may be on a less than equal weight basis, thereby sacrtffcfng part of the gain in absorbent capacity in favor of a reduction in bulk. The absorbent structures used in sanitary napkins preferably have a caliper of from about 0.1 mm to about 2 mm, more preferably from about 0.3 mm to about I mm.
An example of a sanitary napkin comprises a pad of the absorbent t~ Structure of the present invention; a hydrophobic topsheet; and a fluid impervious blotto sheet. The topsheet and the backsheet are placed at opposite sides of the absorbent structure. Optionally, the absorbent structure is wrapped in envelope tissue. Suitable materials for top sheets, bottom sheets and envelope tissue are well known in the art. A more detailed description of sanitary napkins and suitable materials for use therein is found in Duncan and Smith, U.S. Patent 3,871,3?8; Issued March 18, 1975, the disclosure of which is incorporated herein by reference.
TEST METHOOS In describing the present invention in the following examples, certain characteristics of the polymeric gelling agent particles ant the absorbent structures containing them are set forth. Where reported, these characteristics can be determined using the following test methods: Gel Volume of the Gelling Agent Gel volume in terms of grams of synthetic urine absorbed per gram of polymeric gelling agent is determined by swelling the polymer samples in several aliquots of synthetic urine.The amount of such synthetic urine actually absorbed by the polymeric gelling agent is determined by a procedure which involves use of a synthetic urine solution containing Blue Dextran so that optical absorbance measurements can be used to calculate the amount of synthetic urine that is not taken up by the hydrogel which forms.
a) Blue Oextran Solution Preparation A 0.03% Blue Dextran (Bd) solution is prepared by dissolving 0.3 parts of Blue Dextran (Sigma D-5751) in 1000 parts of Synthetic Urine (SU) solution. Synthetic Urine is 15.0 parts of 1% TRITON (RTM) X-100, 60.0 parts of NaCl, 1.8 parts of CaCl22H2O, and 3.6 parts of MgCl26H2O, diluted to 6000 parts with distilled H20. The resulting solution has an absorbance of about 0.25 at its absorbance maximum of 617 nm.
b) Hydrogel Equilibration Aliquots of the hydrogel-forming polymeric gelling agent to be tested are swelled in (1) 20 parts of Synthetic Urine (SU) solution and (11) 20 parts of Blue Dextran (BD) solution. The suspension in the Blue Dextran (BD) solution Is prepared in duplicate. For most hydrogels, 0.1 - 0.25 parts of hydrogel-forming dried powder is required to give a sufficiently high spectrophotometer reading relative to the Blue Dextran reference solution. One hour of equilibration at ambient temperature under gentle stir-bar stirring is usually sufficient for swelling equilibrium to be attained.
After equilibration, a 3 ml aliquot of supernatant is separated from each gel suspension by decantation followed by centrifugation.
c) Gel VolYne Determination The optical absorbency (ABS) of each supernatant is determined spectrophotometrically with an accuracy of 0.001 absorbance units. The Synthetic Urine solution is used as an ABSIO.O reference. The absorbency of the supernatant from the synthetic urine suspension without Blue Dextran should not exceed 0.01 A; higher values indicate scattering from residual hydrogel gel particles or residual#additives, and further centrifugation is necessary. The absorbency of the Blue Dextran supernatants should exceed the absorbency of the Blue Dextran reference solution by at least 0.1 absorbance units.Absorbency values below this range indicate the need to adjust the amount of polymeric gelling agent used to prepare the gel suspension.
d) Gel Volume Calculation The Gel Volume in synthetic urine of the polymeric gelling agent in gms/gm is calculated from (l) the weight fraction of the polymeric gelling agent in the gel suspension and (t1) the ratio of the excluded volume to the total volume of the suspension. Since Blue Dextran is excluded from the hydrogel due to its high molecular weight, this ratio is related to the measured absorbencies.The follow ing equation is used to calculate the gel volume: Gel Volume
* Corrected to a dry weight basis Absorbent Structure Density Reported density measurements are all made under a confining pressure of 9.6 grams/cm2 (0.94 kit). Measurements are made using a Precision Scientific Penetrometer that is modified for caliper measurements.
Absorbent Capacity of Structure The absorbent capacity of an absorbent structure can be determined by an equilibrium demand-absorbency test. In such a test, a 5.4 cm diameter sample of the absorbent structure is placed on a 7.5 cm diameter glass frit tPor E (ASTM 4-8 microns) from Ace Glass) that is maintained in fluid contact with a reservoir containing synthetic urine. In this setup, the reservoir is positioned on the pan of a Mettler Awl60 Analytical Balance. This provides a continuous readout of the weight of synthetic urine in the reservoir and, by difference, the weight of synthetic urine taken up by the absorbent structure. The height of the frit and the height of the reservoir are adjusted to approximately the same level.A confining weight of 0.2 psi (1.38 kPa) is placed on top of the absorbent structure sample.
Using this setup, the number of grams of synthetic urine taken up per gram of structure, once equilibrium is reached, can be determined.
EFFECTIVE EqUILIBRIUM ABSORBENT CAPACITY OF GELLING AGENT PARTICLES This is the difference in grams between the absorbent capacity of a structure containing gelling agent particles, and that of a comparative structure differing in composition and construction from the first only in that the gelling agent particles are omitted, divided by the dry weight of the gelling agent particles.
The absorbent structures herein, as well as disposable absorbent articles containing them, are illustrated by the following examples.
EXAMPLE I An absorbent structure with a basis weight of about 0.072 g/cm2 is prepared by arraying a substantially uniform mixture of about 80X by weight wood pulp fibers and about 20X by weight of non-agglomerated particles of a cross-linked, partially neutralized, sodium polyacrylate gelling agent.
The resulting fibrous web is then calendered to form a structure which has a density of about 0.21 g/cmt. The wood pulp fibers employed are southern soft wood slash pine fibers (Foley fluff). The gelling agent has an equilibrium gel volume of about 24 grams of synthetic urine per gram of gelling agent and a degree of neutralization of about 70X.
The particles of gelling agent are screened such that a No.
25/35 fraction is utilized in this absorbent structure. The 25/35 size fraction contains particles that pass through a U.S.A.
Standard Testing Sieve with 710 micron openings (No. 25 b.S.
Series Alternate Sieve Designation) and are retained on a U.S.A.
Standard Testing Sieve with S00 micron openings (No. 35 U.S.
Series Alternate Sieve Designation). This particle-size fraction is collected between U.S.A. Standard Testing Sieves (Fisher) after thirty minues of sieving with a Ro-Tap (RTM) Sieve Shaker (Tyler). The resultant particles have a mass median particle size between 500 and 710 microns.
The absorbent capacity of the structure containing gelling agent particles of this size fraction is determined using the procedure set forth hereinbefore in the Test Methods section and is found to be 11.4 grams of synthetic urine per gram of structure. Since it is known that the equilibrium capacity of a comparable 100% Foley fluff structure at 0.2 psi is about 6.0 9/9, it is possible to calculate an effective absorbent capacity of the gelling agent in the above structure. This is done by determining the capacity differential in grams between the gelling agent-contafnlng structure and a comparable 100% Foley fluff structure and by dividing this difference by the dry weight in grams of the gelling agent.The effective absorbent capacity of the gelling agent determined in this manner thus represents the unit Increase in equilibrium capacity of the absorbent structure per unit of added hydrogel-forming polymeric gelling agent. For purposes of this invention a comparable structure without the gelling agent is one which has the same basis weight and density as the Foley fluff component of the gelling agent containing structure.Such a comparable structure for this Example I has a basis weight of about 0.057 g/cm2 and a den 4ty of about 0.17 g/cmr. Using this procedure for the Example I structure, the effective absorbent capacity of the gelling agent in the structure is calculated to be 33.0 grams of synthetic urine per gram of gulling agent.
EXAMPLE II Absorbent structures similar to that of Example I with approximately the same concentration of gelling agent are pre pared using different size fractions of the particles of the same type of gelling agent. These structures are also tested for their equilibrium absorbent capacities in the manner described in the Test Methods section. Furthermore, an effective absorbent capacity of the gelling agent in each structure is also calculated in a manner similar to that described In Example I.
A description of the products tested and absorbent capacity results are set forth in Table I.
Table I Effect of Polymeric Gelling Agent (PGA) Particle Size on Equilibrium Absorbent Capacities Structure Effettive PGA PSA Particle Absorbent Absorbent Structure Size Range Capacity Capacity No. (microns) (qrams/#ram) (grams/gram) 1 500-710 11.5* 33.3* 2 355-500 11.2 31.3 3 180-250 10.6* 28.5* 4 125-180 9.9* 25.0* 5 90-125 9,7 23.8 *Average of two determinations The Table I data indicate that Structures 1 and 2 (which contain. particles having mass median particle sizes greater than 400 microns and less than 710 microns) of the present invention provide both a higher absorbent capacity for the structure and a higher effective absorbent capacity of the gelling agent than do similar structures (Structures 3-5) which utilize generally smaller gelling agent particles, having mass median particle sizes less than 400 microns.
EXAMPLE III Absorbent structures similar to that of Examples I and II are prepared using the same components but with varying amounts and sizes of the gelling agent particles in the structures.
Absorbent capacities of such structures and effective absorbent capacity of the gelling agent in each such structure are also determined. Such structures and absorbent capacities are described in Table IS.
Table If Effect of Polymeric Gelling Agent (PGA) Concentration Structure Absorbent Effective PGA Capacity Capacity Approximate PGA (grams/gram) (grams/gram) Concentration Large Small: Large Small: (Wt.%) Particles Particles Particles Particles 0 6.0* 6.0* -- -- 10 9.3* 7,9* 40* 26* 20 11.5* 9.7 33* 24 30 12.8* 11.1* 29* 24* 1500.710 microns 290.125 microns average of duplicate measurements The Table II data indicate that the improvement in the effective absorbent capacity of the gelling agent, which improvement is brought about by using larger particle size gelling agent, diminishes as total gelling agent concentratton in the structure increases.
EXAMPLE IV An absorbent structure similar to that described in Example I is prepared using a cross-linked, sodium polyacrylate gelling agent hazing a ge' volume of about 49 arbns of synthetic urine per gram and a degree of neutralization of about 70X. The partRcle-st2e fraction of such a gelling agent is such that the gelling agent particles pass through a U.S.A. Standard Testing Sieve with 710 micron openings (No. 25 U.S. Series Alternate Sieve Designation) and are retained on a U.S.A. Standard Testing Sieve with 500 micron openings (No. 35 U.S. Series Alternate Sieve Designation). These gelling agent particles are incorpor- ated into the FoleY Fluff structure in a concentration of about 15X.The resulting fibrous web has a basis weight of about 0.05 g/cm2 This web is then calendered to form a structure which has a density of about 0.19 g/cm'.
EXAMPLE V The equilibrium absorbent capacity of, and the effective capacity of gelling agent in, the structure of Example IV are compared with those of similar structures wherein smaller particle size fractions of the gelling agent are employed.
Results are shown in Table III.
Table III Effect of Polymeric Gelling Agent (PGA) Particle Size Using High Gel Volume PGAs Structure Effective PGA PGA PGA Particle Absorbent Absorbent Structure Concentration Size Range Capacity Capacity No. (Wt%) (microns) (grams/gram) (grams/gram) 1 15.2* 500-710 12.2* 46.6* 2 14.5 355-500 12.1 48.0 3 14.6 180-250 11 1 41.3 4 13.0 125-180 10.3 39.4 5 14.5 90-125 10.0 33.5 *Average of two determinations The Table III data indicate that, for this relatively high gel volume gelling agent, Structures l and 2 (which contain particles having mass median particle sizes greater than 400 microns and less than 710 microns) of the present invention provide both a higher absorbent capacity for the structure and a higher effective absorbent capacity of the gelling agent than do similar structures (Structures 3-5) which utilize generally smaller gelling agent particles, having mass median particle sizes less than 400 microns.
EXAMPLE VI A disposable diaper is prepared using an absorbent structure of the present invention as an absorbent core. The absorbent structure is an hourglass-shaped air-laid mixture comprising 26.6 grams of wood pulp fibers (Foley fluff) and S grams of particles of a cross-linked sodium polyacrylate polymeric gelling agent having a gel volume of about 30 grams of synthetic urine per grawi and a degree of neutralization of about 70X. Substantially all of the particles of the polymeric gelling agent range in size from about 355-500 microns. Such particles have a mass median particle size of about 430 microns.
the absorbent structure has nonuniform distribution of gelling agent tSeretn such that the weight percent of gelling agent in the front section of the diaper is 20%, in the crotch section of the diaper is 13S and in the back section of the diaper is 12X. Such a structure is calendered to an average density of about 0.15 g/cm3 and has an average basis weight of about 0.05 g/cm2.
This hourglass-shaped absorbent structure is utilized as an absorbent core in a diaper prepared in general as described in Buell, U.S. Patent 3,860,003; Issued January 1X, 1975. In such a diaper, the hourglass core is overwrapped with envelope tissue and inserted between a polypropylene topsheet and a polyethylene backing sheet. Such a diaper structure is especially effective at using the absorbent capacity of the gelling agent in corny parson with similar diapers employing smaller particle size fractions of the gelling agent.

Claims (5)

1. A composition especially suitable for use as an absorbent gelling agent in fibrous absorbent web structures, said composition comprising a plurality of non-fibrous discrete non-agglomerated particles of a substantially water insoluble slightly cross linked partially neutralised hydrogel forming polymeric gelling agent material wherein (A) said polymeric gelling agent material comprises: (i) from 50 mole percent to 99.999 mole percent of polymerised unsaturated polymerisable acid group containing monomers; and (ii) from 0.001 mole percent to 5 mole percent of a cross linking agent; said polymeric gelling agent material having a degree of neutralization of at least 50% and a gel volume of at least 20 grams of synthetic urine per gram of gelling agent material; and (B) said plurality of particles has a mass median particle size ranging from about 400 to 700 micrometers with no more than 16% by weight of these particles having a particle size less than 200 micrometers and no more than 16% by weight of these particles having a particle size greater than 1000 micrometers.
2. A composition especially suitable for use as an absorbent gelling agent in fibrous absorbent web structures, said composition comprising a plurality of nonfibrous, discrete nonfragile agglomerated particles of a substantially water-insoluble, slightly crosslinked, partially neutralized, hydrogel-forming polymeric gelling agent material wherein: (A) said polymeric gelling agent material comprises: (i) from 50 mole percent to 99.999 mole percent of polymerized unsaturated, polymerizable, acid group containing monomers; and (ii) from 0.001 mole percent to 5 mole percent of a crosslinking agent; said polymeric gelling agent material having a degree of neutralization of at least 50% and a gel volume of at least 20 grams of synthetic urine per gram of gelling agent material; and (B) said plurality of particles has a mass median particle size ranging from 400 to 700 microns, with no more than 16% by weight of these particles having a particle size less than 200 micrometers and no more than 16% by weight of these particles having a particle size greater than 1000 micrometers.
3. A composition according to either one of Claims 1 or 2 wherein (A) the polymeric gelling agent material is selected from polyacrylates and acrylic acl grafted starch and has an equilibrium extractable polymer content in synthetic urine of no more than 17% by weight; and (B) the plurality of gelling agent particles (i) have a mass median particle size in the range 410 to 650 micrometers with no more than 16% by weight of said particles having a particle size less than 210 micrometers and no more than 16% by weight of said particles having a particle size greater than 1000 micrometers, or (ii) have a mass median particle size in the range 420 to 600 micrometers with no more than 16% by weight of the particles having a particle size less than 220 micrometers and no more than 16% by weight of the particles having a particle size greater than 900 micrometers.
4. A composition according to Claim 3 wherein said polymer gelling agent material has a gel volume of from 25 to 60 grams of synthetic urine per gram of gelling agent.
5. A composition according to either one of claims 3 and 4 wherein said plurality of gelling agent particles has the following particle size distribution as determined by ASTM analysis on US Sieve Series screens US Sieve Series Distribution (Wt%) Alternative Designation On No. 14 Up to 0.1 OnNo. 16 Up to 1.0 On No. 20 10-35 On No. 50 Less than 50 On No. 100 Up to 15 Thru No. 100 Less than or equal to 5.
GB9105295A 1987-08-19 1991-03-13 Absorbent structures with gelling agent and absorbent articles containing such structures Expired - Lifetime GB2242195B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8713787A 1987-08-19 1987-08-19
US14690488A 1988-01-22 1988-01-22
GB8819795A GB2208804B (en) 1987-08-19 1988-08-19 Absorbent structures with gelling agent and absorbent articles containing such structures

Publications (3)

Publication Number Publication Date
GB9105295D0 GB9105295D0 (en) 1991-04-24
GB2242195A true GB2242195A (en) 1991-09-25
GB2242195B GB2242195B (en) 1992-04-29

Family

ID=27264037

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9105295A Expired - Lifetime GB2242195B (en) 1987-08-19 1991-03-13 Absorbent structures with gelling agent and absorbent articles containing such structures

Country Status (1)

Country Link
GB (1) GB2242195B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051346A1 (en) * 2000-12-22 2002-07-04 Sca Hygiene Products Ab Absorbing structure

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051346A1 (en) * 2000-12-22 2002-07-04 Sca Hygiene Products Ab Absorbing structure

Also Published As

Publication number Publication date
GB9105295D0 (en) 1991-04-24
GB2242195B (en) 1992-04-29

Similar Documents

Publication Publication Date Title
EP0304319B1 (en) Absorbent structures with gelling agent and absorbent articles containing such structures
US5061259A (en) Absorbent structures with gelling agent and absorbent articles containing such structures
EP0294137B1 (en) Composite absorbent structures
EP0306262B1 (en) Improved composite absorbent structures and absorbent articles containing such structures
US5330822A (en) Particulate, absorbent, polymeric compositions containing interparticle crosslinked aggregates
US5492962A (en) Method for producing compositions containing interparticle crosslinked aggregates
KR100348934B1 (en) Absorption member containing cross-linked aggregates between particles
US5149334A (en) Absorbent articles containing interparticle crosslinked aggregates
US5180622A (en) Absorbent members containing interparticle crosslinked aggregates
KR100259729B1 (en) Absorbent gelling material comprising a dry mixture of at least two types of hydrogel-forming particles and method for making the same
KR100200238B1 (en) Particulate, absorbent, polymeric compositions containing interparticle crosslinked aggregates
CA2159807C (en) Improved absorbent members having improved fluid distribution via low density and basis weight acquisition zones
US5800417A (en) Absorbent composition comprising hydrogel-forming polymeric material and fiber bundles
EP0325416A2 (en) Absorbent members having low density and basis weight acquisition zones and absorbent articles incorporating such members
GB2215609A (en) Thin absorbent articles containing gelling agent
GB2214201A (en) Microfiber-containing absorbent structures and absorbent articles using such structures
US5384179A (en) Particulate polymeric compositions having interparticle crosslinked aggregates of fine precursors
US6905986B2 (en) Composites comprising superabsorbent materials having a bimodal particle size distribution and methods of making the same
GB2242195A (en) Absorbent structures with gelling agent and absorbent articles containing such structures
MXPA02008049A (en) Methods of making composites comprising superabsorbent materials having a bimodal particle size distribution.
US20030135175A1 (en) Articles comprising superabsorbent materials having a bimodal particle size distribution
NZ241163A (en) Hydro gel-forming polymer composition for absorbent structures
MXPA04002443A (en) Composites comprising superabsorbent materials having a bimodal particle size distribution and methods of making the same.

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Expiry date: 20080818